Céline Steverlynck

Statistics

Publications

Citations

125

H-Index

Active since

2009

Affiliations

Institut Pierre-Gilles de Gennes pour la Microfluidique(Current)

Centre National de la Recherche Scientifique

Céline Steverlynck is an author at Institut Pierre-Gilles de Gennes pour la Microfluidique specializing in medicine, oncology, and molecular oncology.

Publications per year

2009–2012

Publications

Potent in Vivo Antiangiogenic Effects of GS-101 (5′-TATCCGGAGGGCTCGCCATGCTGCT-3′), an Antisense Oligonucleotide Preventing the Expression of Insulin Receptor Substrate-1

Salman Al-Mahmood, Sylvie Colin, Nada Farhat et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 35 citations

Life Sciences, Endocrinology, Ophthalmology +15

<scp>LG</scp> 3 fragment of endorepellin is a possible biomarker of severity in <scp>I</scp> g <scp>A</scp> nephropathy

Brigitte Surin, Emmanuelle Sachon, Jean‐Philippe Rougier et al. · PROTEOMICS · 2012 · 32 citations

Medicine, Nephrology, Pathology +14

CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth

William Guilmain, S Cooper Colin, E Legrand et al. · British Journal of Cancer · 2011 · 30 citations · Full text

Medicine, Molecular Biology, Oncology +11

A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth

S Cooper Colin, William Guilmain, Estelle Creoff et al. · British Journal of Cancer · 2011 · 28 citations · Full text

Medicine, Cell Biology, Oncology +14

1–4 of 4